| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07199517 Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People… |
date change Primary completion pushed: 2030-01 -> 2030-01-31 |
| 2026-06-12 | NCT07199517 Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People… |
date change Completion pushed: 2030-07 -> 2030-07-31 |
| 2026-06-11 | NCT04332367 Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or… |
date change Primary completion pushed: 2026-04 -> 2026-09-30 |
| 2026-06-11 | NCT04332367 Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or… |
date change Completion pushed: 2026-04 -> 2026-09-30 |
| 2026-06-11 | NCT05758688 PROton Therapy for Post Surgical Treatment of GYNecologic Cancer |
date change Primary completion pushed: 2026-05 -> 2026-11 |
| 2026-06-11 | NCT05758688 PROton Therapy for Post Surgical Treatment of GYNecologic Cancer |
date change Completion pushed: 2026-11 -> 2026-12 |
| 2026-06-02 | NCT05852860 A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation… |
overall status: "Enrolling By Invitation" → "Active Not Recruiting" |
| 2026-05-27 | NCT06089954 Penn Medicine Biobank Return of Results Program |
overall status: "Enrolling By Invitation" → "Active Not Recruiting" |
| 2026-05-27 | NCT06089954 Penn Medicine Biobank Return of Results Program |
date change Primary completion pushed: 2026-04-01 -> 2026-07-01 |
| 2026-05-27 | NCT06089954 Penn Medicine Biobank Return of Results Program |
date change Completion pushed: 2026-08-31 -> 2026-09-30 |
| 2026-05-27 | NCT04889716 CAR-T Followed by Bispecific Antibodies |
Primary endpoint(s) modified |
| 2026-05-27 | NCT04889716 CAR-T Followed by Bispecific Antibodies |
Enrollment reduced: 42 -> 23 participants |
| 2026-05-27 | NCT04523857 ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in… |
Enrollment reduced: 66 -> 44 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06591819 | Hypofractionated WPPT With HDR Boost | Prostate Cancer | Recruiting |
| NCT05496036 | Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma | Merkel Cell Carcinoma | Recruiting |
| NCT04841148 | Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast… | Breast Cancer | Recruiting |
| NCT04523857 | ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in… | Breast Cancer | Recruiting |
| NCT04889716 | CAR-T Followed by Bispecific Antibodies | Large B-cell Lymphoma | Recruiting |
| NCT06458439 | Epcoritamab-CAR T Cells for Large B-cell Lymphomas | Lymphoma, Non-Hodgkin | Recruiting |
| NCT04339036 | CapTemY90 for Grade 2/3 NET Liver Metastases | Neuroendocrine Tumor Grade 2 | Recruiting |
| NCT05916196 | [18F]FES PET/.CT in Uterine Cancer | Uterine Cancer | Recruiting |
| NCT04332367 | Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or… | Non-small Cell Lung Cancer | Recruiting |
| NCT05758688 | PROton Therapy for Post Surgical Treatment of GYNecologic Cancer | Cervical Cancer | Recruiting |
| NCT02153229 | Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant… | Epitheliod Malignant Pleural Mesothelioma | Active, Not Recruiting |
| NCT04221503 | Niraparib/TTFields in GBM | Glioblastoma | Active, Not Recruiting |
| NCT05318027 | ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy | Lung Cancer | Active, Not Recruiting |
| NCT05714657 | Shortened Course Adjuvant Radiotherapy Following TORS | HPV-Associated Oropharyngeal Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT07059611 | Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma | Gastric Adenocarcinoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT04691817 | Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell… | Lung Cancer, Nonsmall Cell | Recruiting |
| NCT04454528 | BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy | Breast Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT03546829 | Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With… | Early Stage Non-Small Cell Lung Cancer | Recruiting |
| NCT03863457 | [18F] F-GLN by PET/CT in Breast Cancer | Breast Cancer | Recruiting |
| NCT07114939 | FTT PET/CT in Pancreatic Neuroendocrine Tumors | Neuroendocrine Carcinoma Metastatic | Recruiting |
| NCT06413355 | FAPI-74 PET/CT in Adults With Fibrosis | Fibrosis (Morphologic Abnormality) | Recruiting |
| NCT05488522 | SBRT With Atezo/Bev for HCC | Hepatocellular Carcinoma | Recruiting |
| NCT02637934 | Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer… | Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Recruiting |
| NCT06586255 | Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer | Urothelial Carcinoma Bladder | Recruiting |
| NCT02213497 | Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in… | Esophageal Cancer | Active, Not Recruiting |